Caris Life Sciences, Inc. has disclosed an amendment to its Schedule 13G filing, revealing that FMR LLC now beneficially owns 13.4% of the company's common stock. This significant stake underscores FMR LLC's growing interest in Caris Life Sciences, a prominent player in the medical laboratory services industry.
The filing, dated November 5, 2026, indicates that FMR LLC holds a total of 37,795,316.66 shares, with sole voting power over 37,793,788 shares. Abigail P. Johnson, a key figure at FMR LLC, is also noted as a beneficial owner of the same number of shares, further solidifying the family's influence within the company.
Background
Caris Life Sciences, Inc. operates within the medical laboratory services sector, classified under SIC code 8071. The company is traded on the Nasdaq under the ticker symbol CAI. Caris Life Sciences focuses on providing advanced molecular profiling services to help guide treatment decisions in oncology.
Recent filings include a 10-Q and an 8-K on November 4, 2026, which provide further context to the company's financial health and operational updates.
What the Filing Says
The recent Schedule 13G/A filing states, "This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies." This highlights the extensive reach of FMR LLC's investment strategy.
Impact
This development may affect various stakeholders, including current shareholders, potential investors, and competitors in the medical laboratory services industry. FMR LLC's significant ownership stake may influence Caris Life Sciences' strategic direction and operational decisions.
What's Next
The filing does not say what happens next.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





